Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2010-07-23Clinical Trial Update: Improving Door-to-Balloon Time in STEMI [NA]
Clinical trial update related to improving door-to-balloon time in ST-elevation myocardial infarction (STEMI), sponsored by St. Francis Hosp…
-
CLINICAL_TRIALS trial_result · 2010-07-16Clinical Trial Update: Fluvastatin in the Therapy of Acute Coronary Syndrome [Phase 4]
Phase 4 clinical trial evaluating fluvastatin in patients with acute coronary syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2010-07-13Clinical Trial Update: FIT (Fast Infarction Treatment): Complete Revascularization During Primary Percutaneous Coronary Intervention (PCI) Can be Achieved Safely With an Improved Clinical Outcome During the Indexed Hospitalization. [Phase 3]
A Phase 3 trial exploring whether complete revascularization during primary PCI can be achieved safely and improve outcomes during the index…
-
CLINICAL_TRIALS research · 2010-07-08Clinical Trial Update: Dallas Heart Study 2: Return Clinic Visit for the Dallas Heart Study Cohort
This clinical trial update reports completion of the Dallas Heart Study 2 return clinic visit for the Dallas Heart Study cohort.
-
FDA approval · 2010-07-06FDA Approved: ATENOLOL — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for atenolol submitted by Rising Pharma Holdings, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-06-16Clinical Trial Update: REsearching Coronary REduction by Appropriately Targeting Euglycemia (RECREATE Pilot Study) [Phase 3]
The RECREATE Pilot Study, a Phase 3 trial evaluating targeting euglycemia to reduce coronary events in hyperglycemic patients, has completed…
-
CLINICAL_TRIALS trial_result · 2010-06-04Clinical Trial Update: The Prognostic Significance of a Fragmented QRS Complex After Primary Percutaneous Coronary Intervention
This update evaluates whether fragmented QRS complexes after primary percutaneous coronary intervention have prognostic value for major adve…
-
CLINICAL_TRIALS trial_result · 2010-05-28Clinical Trial Update: INSTANT: INtegrilin Plus STenting to Avoid Myocardial Necrosis Trial [Phase 3]
This INSTANT Phase 3 trial update notes completion of the study evaluating Integrilin (eptifibatide) with stenting to prevent myocardial nec…
-
FDA approval · 2010-05-18FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's supplemental application for clopidogrel bisulfate, a generic version of clopidogrel. The ap…
-
FDA approval · 2010-05-07FDA Approved: LISINOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' lisinopril supplemental application (ANDA 075903), making a generic lisinopril tablet available with ap…
-
CLINICAL_TRIALS research · 2010-05-07Clinical Trial Update: A Structuralised Sick-leave Program Compared to Usual Care Sick Leave Management in Patients After an Acute Myocardial Infarction [NA]
A clinical trial update comparing a structured sick-leave program to usual care for patients after a myocardial infarction, sponsored by Osl…
-
CLINICAL_TRIALS trial_result · 2010-05-04Clinical Trial Update: Efficacy of Early Administration of Clotinab in Acute Myocardial Infarction [Phase 4]
This clinical trial update reports Phase 4 results on the efficacy of early administration of Clotinab for acute myocardial infarction.
-
CLINICAL_TRIALS trial_result · 2010-04-26Clinical Trial Update: Efficacy Of Eptifibatide Compared To Abciximab In Primary Percutaneous Coronary Intervention (PCI) For Acute ST Elevation Myocardial Infarction (STEMI) [Phase 3]
Phase 3 trial results comparing eptifibatide with abciximab during primary PCI for acute STEMI.
-
CLINICAL_TRIALS trial_result · 2010-04-22Clinical Trial Update: Tirofiban Intracoronary Bolus-only Versus Intravenous Bolus Plus Infusion in STEMI Patients [Phase 3]
Phase 3 trial comparing intracoronary bolus-only tirofiban versus intravenous bolus plus infusion in STEMI patients has completed; the updat…
-
CLINICAL_TRIALS trial_result · 2010-04-13Clinical Trial Update: Tailoring Of Platelet Inhibition to Avoid Stent Thrombosis [Phase 2]
This Phase 2 clinical trial assessing tailoring of platelet inhibition to prevent stent thrombosis in patients with coronary artery disease …
-
CLINICAL_TRIALS trial_result · 2010-03-24Clinical Trial Update: Additive Effect of Ezetimibe Upon Simvastatin During Myocardial Infarction [Phase 4]
Phase 4 trial evaluating whether adding ezetimibe to simvastatin provides additional benefit during myocardial infarction; the study is comp…
-
CLINICAL_TRIALS trial_result · 2010-03-24Clinical Trial Update: Safety and Efficacy of Bone Marrow Cell Transplantation in Humans Myocardial Infarction [Phase 1, Phase 2]
Phase 1/2 clinical trial update assessing the safety and efficacy of bone marrow cell transplantation in patients with acute myocardial infa…
-
CLINICAL_TRIALS trial_result · 2010-03-16Clinical Trial Update: Value of Abciximab in Patients With AMI Undergoing Primary PCI After Clopidogrel Pretreatment (BRAVE 3) [Phase 4]
Phase 4 BRAVE 3 trial evaluating abciximab in patients with acute myocardial infarction undergoing primary PCI after clopidogrel pretreatmen…
-
FDA approval · 2010-03-12FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for metoprolol tartrate from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS research · 2010-03-12Clinical Trial Update: Infusion of a Single Dose of Erythropoietin to Prevent Injury in an Ischemia Reperfusion Forearm Model [NA]
A clinical trial update describing the use of a single dose of erythropoietin to prevent ischemia-reperfusion injury in a forearm model; the…
-
FDA approval · 2010-03-10FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Hospira, Inc.)
FDA approved Hospira's supplemental application for metoprolol tartrate.
-
CLINICAL_TRIALS trial_result · 2010-02-23Clinical Trial Update: Safety And Feasibility of Early DischargE - a Prospective And Randomized Trial of Low-risk Primary Percutaneous Coronary Intervention (PCI) Patients [NA]
The document reports the completion of a prospective randomized trial evaluating the safety and feasibility of early discharge after low-ris…
-
CLINICAL_TRIALS research · 2010-02-22Clinical Trial Update: The BEACON Registry: Best Expert Agreement for Care of Occult Myocardial Infarction (MI) Nationally
The BEACON Registry study evaluating expert consensus for the care of occult myocardial infarction has been terminated.
-
CLINICAL_TRIALS research · 2010-02-17Clinical Trial Update: Safety Study of Allogeneic Mesenchymal Precursor Cells (MPCs) in Subjects With Recent Acute Myocardial Infarction [Phase 1, Phase 2]
This document provides an update on a Phase 1/2 safety study evaluating allogeneic mesenchymal precursor cells in patients recently experien…
-
CLINICAL_TRIALS research · 2010-02-02Clinical Trial Update: Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation [Phase 2, Phase 3]
This document provides an update on a Phase 2/3 trial comparing ATI-5923, a novel vitamin K antagonist, with warfarin for patients requiring…